Drug Information

Drug General Information
Drug ID
D0D9FA
Former ID
DNC014161
Drug Name
(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530282]
Formula
C17H18INO2
Canonical SMILES
C1COC(CN1)C(C2=CC=CC=C2)OC3=CC=C(C=C3)I
InChI
1S/C17H18INO2/c18-14-6-8-15(9-7-14)21-17(13-4-2-1-3-5-13)16-12-19-10-11-20-16/h1-9,16-17,19H,10-12H2/t16-,17+/m1/s1
InChIKey
SFIZDMBLVRMOCD-SJORKVTESA-N
PubChem Compound ID
45487461
Target and Pathway
Target(s) Sodium-dependent dopamine transporter Target Info Inhibitor [530282]
Sodium-dependent serotonin transporter Target Info Inhibitor [530282]
KEGG Pathway Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Alcoholismhsa04726:Serotonergic synapse
NetPath Pathway TCR Signaling Pathway
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
Parkinson disease
Dopamine receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway
5HT2 type receptor mediated signaling pathway
5HT3 type receptor mediated signaling pathway
5HT4 type receptor mediated signaling pathway
Pathway Interaction Database Alpha-synuclein signaling
Reactome Na+/Cl- dependent neurotransmitter transporters
WikiPathways Monoamine Transport
NRF2 pathway
Dopaminergic Neurogenesis
Parkinsons Disease Pathway
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
Neurotransmitter Clearance In The Synaptic CleftWP727:Monoamine Transport
SIDS Susceptibility Pathways
Synaptic Vesicle Pathway
Serotonin Transporter Activity
References
Ref 530282Bioorg Med Chem Lett. 2009 Sep 1;19(17):4996-8. Epub 2009 Jul 16.Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.
Ref 530282Bioorg Med Chem Lett. 2009 Sep 1;19(17):4996-8. Epub 2009 Jul 16.Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.